Valuation: Albert David Limited

Market Cap 3.35B 35.18M 30.76M 28.27M 26.35M 49.98M 50.73M 339M 132M 1.65B 132M 129M 5.67B P/E 2024
8.14x
P/E 2025 26.9x
Enterprise Value 1.04B 10.89M 9.52M 8.75M 8.15M 15.47M 15.7M 105M 40.82M 510M 40.87M 39.99M 1.76B EV / Sales 2024
0.92x
EV / Sales 2025 0.67x
Free-Float
35.96%
Yield 2024
1.07%
Yield 2025 0.62%
1 day+0.60%
1 week+1.57%
Current month+2.91%
1 month+0.58%
3 months+9.93%
6 months-4.40%
Current year-2.31%
1 week 691.1
Extreme 691.1
720.9
1 month 683.5
Extreme 683.5
737.95
Current year 579.9
Extreme 579.9
819.6
1 year 579.9
Extreme 579.9
957.5
3 years 579.9
Extreme 579.9
1,753.95
5 years 479.05
Extreme 479.05
1,753.95
10 years 263
Extreme 263
1,753.95
Manager TitleAgeSince
Chief Executive Officer 52 11/05/2026
Director of Finance/CFO - 30/11/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 13/11/2024
Chairman 73 29/12/2009
Director/Board Member 68 30/03/2014
Change 5-day change 1-year change 3-year change Capi.($)
+0.60%+1.57% - - 42.45M
+1.81%+2.25%+13.55%+81.13% 47.15B
-2.54%+4.24%+63.60%+114.38% 37.94B
+0.15%+1.26%-2.63%+43.67% 12.35B
+3.71%+3.56%+14.59%+95.63% 11.52B
+1.75%-1.34%+33.25%+122.84% 8.93B
+0.66%-0.57%+19.28%+45.55% 7.14B
+0.71%+3.35%+54.96%-7.18% 7.02B
+0.68%+2.63%+24.92%+227.07% 6.51B
+9.99%+27.85%-16.33%+28.50% 5.98B
Average +1.75%+4.03%+22.80%+83.51% 16.06B
Weighted average by Cap. +0.85%+3.27%+28.17%+88.74%

Financials

2024 2025
Net sales 3.62B 38.07M 33.28M 30.58M 28.51M 54.07M 54.89M 367M 143M 1.78B 143M 140M 6.14B 3.46B 36.31M 31.75M 29.17M 27.19M 51.58M 52.36M 350M 136M 1.7B 136M 133M 5.86B
Net income 754M 7.92M 6.92M 6.36M 5.93M 11.25M 11.42M 76.4M 29.7M 371M 29.73M 29.09M 1.28B 172M 1.81M 1.58M 1.45M 1.35M 2.57M 2.6M 17.42M 6.77M 84.55M 6.78M 6.64M 291M
Net Debt -2.82B -29.61M -25.88M -23.79M -22.17M -42.05M -42.69M -286M -111M -1.39B -111M -109M -4.78B -2.31B -24.3M -21.24M -19.52M -18.19M -34.51M -35.03M -234M -91.1M -1.14B -91.2M -89.24M -3.92B
Logo Albert David Limited
Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.
Employees
1,805
Date Price Change Volume
03/07/26 719.60 +0.60% 2,220
02/07/26 ₹715.30 -0.27% 414
01/07/26 ₹717.25 +2.57% 1,611
30/06/26 ₹699.25 +0.21% 1,147
29/06/26 ₹697.75 -1.52% 1,634